0001099219false00010992192025-02-182025-02-180001099219us-gaap:CommonStockMember2025-02-182025-02-180001099219us-gaap:SeriesAPreferredStockMember2025-02-182025-02-180001099219us-gaap:SeriesEPreferredStockMember2025-02-182025-02-180001099219us-gaap:SeriesFPreferredStockMember2025-02-182025-02-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 18, 2025
METLIFE, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1-15787 |
|
13-4075851 |
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
200 Park Avenue, |
New York, |
NY |
|
|
10166-0188 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
(212) 578-9500
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
|
|
|
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
|
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
|
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
|
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, par value $0.01 |
MET |
New York Stock Exchange |
Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01 |
MET PRA |
New York Stock Exchange |
Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E |
MET PRE |
New York Stock Exchange |
Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F |
MET PRF
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On February 18, 2025, MetLife, Inc. issued a news release announcing the declaration of (i) a semi-annual dividend of $29.375 per share on MetLife, Inc.’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, $1,000 liquidation preference per share; (ii) a quarterly dividend of $351.5625 per share on MetLife, Inc.’s 5.625% non-cumulative preferred stock, Series E, $25,000 liquidation preference per share, which is $0.3515625 per depositary share, each representing a 1/1,000th interest in a share of Series E Preferred Stock; (iii) a quarterly dividend of $296.875 per share on MetLife, Inc.’s 4.75% non-cumulative preferred stock, Series F, $25,000 liquidation preference per share, which is $0.296875 per depositary share, each representing a 1/1,000th interest in a share of Series F Preferred Stock; (iv) a semi-annual dividend of $19.250 per share on MetLife, Inc.’s 3.850% fixed rate reset non-cumulative preferred stock, Series G, $1,000 liquidation preference per share; and (v) a quarterly dividend of $0.35516415 per share on MetLife, Inc.’s floating rate non-cumulative preferred stock, Series A, $25 liquidation preference per share, subject to final confirmation that it has met the financial tests specified in the Series A preferred stock certificate of designations. A copy of the news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
|
|
|
|
|
|
|
|
101 |
Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language) |
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
METLIFE, INC. |
|
|
By: |
|
/s/ Timothy J. Ring |
|
|
Name: |
|
Timothy J. Ring |
|
|
Title: |
|
Senior Vice President and Secretary |
Date: February 18, 2025
EX-99.1
2
ex991newsrelease.htm
EX-99.1
Document
|
|
|
|
|
|
|
For Immediate Release | Global Communications | MetLife, Inc. |
MetLife Announces First Quarter 2025 Preferred Stock Dividend Actions
Declares Series D, E, F and G Preferred Stock Dividends
Declares Series A Preferred Stock Dividend, Subject to Final Confirmation
NEW YORK, February 18, 2025 — MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends:
•Semi-annual dividend of $29.375 per share on the company’s 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share.
•Quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE: MET PRE).
•Quarterly dividend of $296.875 per share on the company’s 4.75% non-cumulative preferred stock, Series F, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.296875 per depositary share (NYSE: MET PRF).
•Semi-annual dividend of $19.250 per share on the company’s 3.850% fixed rate reset non-cumulative preferred stock, Series G, with a liquidation preference of $1,000 per share.
•Quarterly dividend of $0.35516415 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA), subject to the final confirmation that the company has met the financial tests specified in the certificate of designations for the Series A preferred stock, which the company anticipates will be made and announced on or about March 5, 2025. The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock and will set an ex-dividend date after the confirmatory announcement.
The above dividends will be payable March 17, 2025, to shareholders of record as of Feb. 28, 2025 (including Series A, due to the Series A record date occurring on Sunday, March 2, 2025).
# # #
Contacts:
|
|
|
|
|
|
For Media:
Dave Franecki
973-264-7465
Dave.Franecki@metlife.com
|
For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com
|
About MetLife
MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.
Forward-Looking Statements
The forward-looking statements in this news release, using words such as “will,” are based on assumptions and expectations that involve risks and uncertainties, including the “Risk Factors” MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife’s future results could differ, and it does not undertake any obligation to publicly correct or update any of these statements.